Navigation Links
New Drug That Might Help Congestive Heart Failure Patients

Most patients with congestive heart failure respond to standard treatments, which include diuretics, ACE inhibitors and beta-blockers. However, nearly 30 percent of these patients return to the hospital //within two months, and some of the medications can cause serious side effects such as electrolyte abnormalities and worsening kidney function. Researchers say a new drug Tolvaptan may be more effective than existing medications for treating patients with congestive heart failure.

Patients are usually hospitalized because of fluid retention, which occurs when the body overcompensates for a weak heart. When the heart struggles to beat efficiently, the brain produces a hormone called vasopressin, which constricts blood vessels and causes fluid retention. Researchers studied Tolvaptan -- a drug that targets vasopressin -- to determine if it effectively reduces fluid retention.

More than 300 patients with severe heart failure participated in the study. Researchers divided the participants into four groups and followed them for seven weeks. Patients received either 30 milligrams, 60 milligrams or 90 milligrams of Tolvaptan or a placebo in addition to standard medications. Results of the study showed patients who took Tolvaptan weighed less within 24 hours, indicating a decrease in fluid retention. The mortality rate was also lower for those in the Tolvaptan group. Researchers say there were no changes in worsening heart failure between the groups at 60 days.

Based on the results of the above study researchers conclude saying that they now have an agent that appears promising and safe.
'"/>




Page: 1

Related medicine news :

1. Anemia Treatment for Cancer Patients Might Not be a Good Idea.
2. Tomatoes Might Inhibit the Development Of Prostate Cancer
3. Mad Cow Disease Might Be Linked to Blood Transfusions
4. Strategies That Might Lower Blood Pressure Questioned
5. Factors That Might Increase The Risk Of Schizophrenia
6. A Drug That Might Relieve Chronic Cough
7. Biochemical Markers Might Help Predict Heart Problems
8. Yoga Might Be Helpful For Cancer Patients
9. Healthcare Professionals Might Want To Rethink Their Dress Code
10. Embryonic Cells Might Prevent Parkinson’s Disease From Worsenin
11. Counting Calories Might Be The Ideal Way To Stay Healthy
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/20/2017)... Texas (PRWEB) , ... September 20, 2017 , ... ... in the Orthodontics and Clear Aligner clinical and commercial support services market) has ... of Dentistry (PGSD) in Sydney, Australia. , The PGSD is the first ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... In just ... Brain Booster has already been receiving positive feedback from customers trying the product for ... , Daily Brain Booster was developed by neurosurgeon Shawn Moore, MD, for everyone ...
(Date:9/20/2017)... , ... September 20, 2017 , ... ... of older Americans at risk of price gouging for their prescription drugs, according ... (TSCL) . “Because Medicare isn’t negotiating on our behalf, there’s no consistency in ...
(Date:9/20/2017)... ... , ... “RECYCLED Ezekiel's Plan for Freedom from ADDICTION”: A ... is the creation of published author, Bill Miller. Bill Miller has a ... more than a decade of addiction to prescription drugs. He has a ...
(Date:9/20/2017)... , ... September 20, 2017 , ... “Psalms of Humidity”: ... peace of mind and move the readers one step closer to God. “Psalms of ... realized that his mistakes that have been made within his life are the very ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... N.Y. , Sept. 6, 2017   PDI , ... announced it will host an educational session focused on ... bloodstream infection (CLABSI) prevention at the 2017 Annual Scientific ... which will take place at the Phoenix ... from Sept. 16-19, will also feature PDI,s ...
(Date:9/5/2017)... N.J. , Sept. 5, 2017  Getinge, ... has created a vibrant charitable donation program -- ... and support congenital heart defect research by The ... providers and the general public are encouraged to ... and submit the completed artwork to the gallery ...
(Date:9/1/2017)... 1, 2017  Bayer will present the latest research from ... Medical Oncology (ESMO) 2017 Congress, September 8-12 in ... preclinical and clinical data on Bayer,s marketed portfolio and late-stage ... "We value the ... cancer research at ESMO," said Carsten Brunn , Head ...
Breaking Medicine Technology: